WCN25-2926 BALANCING CARDIOVASCULAR RISK: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION IN HEMODIALYSIS PATIENTS AMID POTASSIUM CHALLENGES AND HYPOTENSION RISK

WCN25-2926 BALANCING CARDIOVASCULAR RISK: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION IN HEMODIALYSIS PATIENTS AMID POTASSIUM CHALLENGES AND HYPOTENSION RISK

Saved in:

Bibliographic Details
Main Authors:	Xavier E. Guerra-Torres, Iván G. Arenas Moncaleano, Maribel Monroy Condori, Jorge Luis Morales Montoya, Gloria Antón Perez
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924025907
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
by: Nancy Houston Miller
Published: (2010-01-01)

Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
by: Miyeon Kim, et al.
Published: (2025-05-01)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
by: Eliecer Coto, et al.
Published: (2021-03-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
by: Audrey Koitka, et al.
Published: (2008-01-01)

Renin‐Angiotensin‐Aldosterone System Profiling in Horses Before and After Exercise
by: Todd Holbrook, et al.
Published: (2025-03-01)

Revisiting the renin-angiotensin-aldosterone system in the eye: Mechanistic insights and pharmacological targets
by: Francesco Buonfiglio, et al.
Published: (2025-06-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
by: Miklós Fagyas, et al.
Published: (2014-01-01)

Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2015-01-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction
by: Susan A. S. Farhadi, et al.
Published: (2019-01-01)

IS IT WORTH TO DISCONTINUE DRUGS BLOCKING THE ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-07-01)

Contribution of Four Polymorphisms in Renin-Angiotensin-Aldosterone-Related Genes to Hypertension in a Thai Population
by: Pimphen Charoen, et al.
Published: (2019-01-01)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
by: Miklós Fagyas, et al.
Published: (2014-01-01)

Upregulation of the Renin-Angiotensin-Aldosterone-Ouabain System in the Brain Is the Core Mechanism in the Genesis of All Types of Hypertension
by: Hakuo Takahashi
Published: (2012-01-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM GENES POLYMORPHISM AND RELATION WITH VASOPRESSORS IN ESSENTIAL HYPERTENSION AMONG DAGESTAN INHABITANTS
by: M. Z. Saidov, et al.
Published: (2017-05-01)

Renin Angiotensin Aldosterone System Gene Polymorphisms among Type 2 Diabetic Patients with Retinopathy and Nephropathy
by: Vaishali S. Pawar, et al.
Published: (2024-12-01)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Role of renin-angiotensin-aldosterone system gene polymorphisms in the development of diastolic dysfunction in female patients with hypertension
by: Mariya A. Grenaderova, et al.
Published: (2025-01-01)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
by: Davide Stolfo, et al.
Published: (2019-05-01)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
by: Giuseppe MC Rosano, et al.
Published: (2019-11-01)

The outcomes of renin-angiotensin-aldosterone system inhibition and immunosuppressive therapy in children with X-linked Alport syndrome
by: Gülşah Özdemir, et al.
Published: (2023-06-01)

Effect of Age on Aldosterone–Renin Ratio in Screening Primary Aldosteronism
by: Ning Peng, et al.
Published: (2025-03-01)

WCN24-1306 THERAPEUTIC APPROACH TO HYPONATREMIA WITH ORAL UREA: BEYOND FLUID RESTRICTION. CASE SERIES FROM A MEDIUM-SIZED HOSPITAL IN SPAIN
by: Xavier E. Guerra-Torres, et al.
Published: (2024-04-01)

WCN24-1554 KNOWLEDGE AND APPLICATION OF THE 2021 SPANISH CONSENSUS DOCUMENT FOR THE DETECTION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE FOR PRIMARY CARE PHYSICIANS (KGAP SURVEY)
by: Xavier E. Guerra-Torres, et al.
Published: (2024-04-01)

Preoperative long-term use of renin-angiotensin-aldosterone system blockers increases the risk of acute kidney injury after coronary artery bypass grafting
by: Xiaokang Xu, et al.
Published: (2025-12-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Acquisition of renin-angiotensin-aldosterone system inhibitors for the treatment of cardiovascular diseases in regions of the Far Eastern Federal District
by: M. S. Soboleva, et al.
Published: (2020-04-01)

Association of the ADRB2 rs1042714 variant with retinopathy of prematurity highlights the importance of the renin-angiotensin-aldosterone system
by: Anna Chmielarz-Czarnocińska, et al.
Published: (2025-04-01)

Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic
by: E. V. Sayutina, et al.
Published: (2022-03-01)

Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system
by: L. M. Resnick, et al.
Published: (2011-12-01)

Correlation of serum chloride concentrations with components of the renin‐angiotensin‐aldosterone system in a dog with congestive heart failure
by: Cailey Banken, et al.
Published: (2024-11-01)

Dynamics of renin-angiotensin-aldosteron system and lipid profile in hypertensive hypothyrosis patients during the process of thyroid function compensation
by: P. Kh. Dzhanashiya, et al.
Published: (2004-12-01)

TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
by: Sh. V. Akhadov, et al.
Published: (2009-06-01)

Impact of Renin–Angiotensin–Aldosterone System (RAAS) Gene Polymorphism in Essential Hypertension and Antihypertensive Drug Therapy: A Review
by: Archana Adhikari, et al.
Published: (2025-01-01)

Post hoc comparison of the intrarenal and circulating renin‐angiotensin(‐aldosterone) systems in cats with ischemia‐induced chronic kidney disease
by: Jane H. C. Huang, et al.
Published: (2025-06-01)